Tripartite motif 10 regulates cardiac hypertrophy by targeting the PTEN/AKT pathway
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tripartite motif 10 regulates cardiac hypertrophy by targeting the PTEN/AKT pathway
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-04-28
DOI
10.1111/jcmm.15257
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ubiquitin proteasome system (UPS) activation in the cardiachypertrophy of hyperthyroidism
- (2019) Caroline Antunes Lino et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation
- (2019) Xin Xie et al. Science Advances
- Silencing of TRIM10 alleviates apoptosis in cellular model of Parkinson's disease
- (2019) Qiong Huang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Conserved structural and functional aspects of the tripartite motif gene family point towards therapeutic applications in multiple diseases
- (2018) Liubov V. Gushchina et al. PHARMACOLOGY & THERAPEUTICS
- A systematic view on E3 ligase Ring TRIMmers with a focus on cardiac function and disease
- (2018) Ankush Borlepawar et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Protein Tyrosine Phosphatases as Potential Regulators of STAT3 Signaling
- (2018) Mihwa Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Emergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy
- (2018) Ishita Gupta et al. Frontiers in Genetics
- TRIM24 protein promotes and TRIM32 protein inhibits cardiomyocyte hypertrophy via regulation of dysbindin protein levels
- (2017) Ankush Borlepawar et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tripartite motif 32 prevents pathological cardiac hypertrophy
- (2016) L. Chen et al. CLINICAL SCIENCE
- Tripartite Motif 8 Contributes to Pathological Cardiac Hypertrophy Through Enhancing Transforming Growth Factor β–Activated Kinase 1–Dependent Signaling PathwaysNovelty and Significance
- (2016) Lijuan Chen et al. HYPERTENSION
- Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
- (2015) Yow Keat Tham et al. ARCHIVES OF TOXICOLOGY
- Extracellular high-mobility group box 1 mediates pressure overload-induced cardiac hypertrophy and heart failure
- (2015) Lei Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Quantification of Cardiomyocyte Hypertrophy by Cardiac Magnetic Resonance
- (2013) Otavio R. Coelho-Filho et al. CIRCULATION
- Signaling effectors underlying pathologic growth and remodeling of the heart
- (2013) Jop H. van Berlo et al. JOURNAL OF CLINICAL INVESTIGATION
- Cardiac Muscle Ring Finger-1 Increases Susceptibility to Heart Failure In Vivo
- (2009) Monte S. Willis et al. CIRCULATION RESEARCH
- Downregulation of the Spi-1/PU.1 oncogene induces the expression of TRIM10/HERF1, a key factor required for terminal erythroid cell differentiation and survival
- (2008) Rand Blaybel et al. CELL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search